OmniStar Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
OmniStar Financial Group's EW Position: Q1 2022 in Review
OmniStar Financial Group sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 1,956 shares — an estimated $253K sold.
OmniStar Financial Group first reported a position in EW in Q4 2017 and held it in 16 quarters. The position peaked at $690K in Q1 2019. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.
- OmniStar Financial Group reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
- OmniStar Financial Group sold 1,956 Edwards Lifesciences shares in Q1 2022, an estimated $253K.
- OmniStar Financial Group first reported a position in Edwards Lifesciences in Q4 2017 and held it in 16 quarters.
- OmniStar Financial Group's Edwards Lifesciences position peaked at $690K in Q1 2019.
- 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.
Based on OmniStar Financial Group's 13F filing for Q1 2022, filed 5 May 2022.